media-45-stamfordadvocate-asthma-study

STAMFORD ADVOCATE | 12.6.18

Stamford-Based Sema4 to Co-Lead Asthma Study

“Health care testing company Sema4 announced this week it would help launch an asthma study that aims to advance diagnoses and treatments of the chronic respiratory disease. Sema4, the Mount Sinai Health System and Sanofi are partnering on the five-year assessment of nearly 1,200 asthma patients in the U.S. to better understand the source of asthma attacks, the disease‚Äôs varying impact on patients, and the potential of certain therapies. For Sema4, the findings would help to develop asthma tests…”